Pharmaceutical Patent Analyst
Q3IF2.1SJR0.264
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.264 | Q3 | 38.8% | |
| 2024 | 2.1 | Q3 | 37.4% | 0.300 | Q3 | 45.7% |
| 2023 | 1.8 | Q3 | 33.8% | 0.351 | Q2 | 53.6% |
| 2022 | 1.3 | 19.6% | 0.233 | Q3 | 42.7% | |
| 2021 | — | 24.0% | 0.331 | Q2 | 54.5% | |
| 2020 | — | — | 0.247 | Q3 | 43.6% | |
| 2019 | — | — | 0.247 | Q2 | 46.1% | |
| 2018 | — | — | 0.307 | Q2 | 50.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2046-8962
ISSN
2046-8954
region
Western Europe
coverage
2012-2024